However, neoantigen vaccines spontaneously upregulate the expression of surface molecules (such as PD-1, TIM3 and CTLA-4) in neoantigen-specific T cells and/or PD-L1 in tumor cells, which in turn impedes the function of the neoantigen vaccines (71). This evidence concerns the gene CTLA4 and neoplasm.